Hepatic candidiasis occurs in which patient population?

Prepare for the WCUI/Smith Chason Exit Assessment – Abdomen, Vascular, OB/GYN Test. Enhance your study with flashcards and detailed multiple choice questions, complete with hints and explanations. Master your exit exam with confidence!

Multiple Choice

Hepatic candidiasis occurs in which patient population?

Explanation:
Hepatic candidiasis is most likely in patients with weakened immune defenses because Candida can invade the bloodstream and seed the liver when the body's immune containment is compromised. This invasive, disseminated form of candidiasis often occurs in neutropenic individuals, those with advanced HIV/AIDS, cancer patients on chemotherapy, organ transplant recipients, or people with prolonged IV lines or broad-spectrum antibiotic use. In healthy individuals, Candida infections are usually limited to mucosal surfaces rather than spreading to the liver. While elderly patients with liver disease are at higher risk for infections in general, the pattern that characterizes hepatic candidiasis is strongest in immunocompromised hosts.

Hepatic candidiasis is most likely in patients with weakened immune defenses because Candida can invade the bloodstream and seed the liver when the body's immune containment is compromised. This invasive, disseminated form of candidiasis often occurs in neutropenic individuals, those with advanced HIV/AIDS, cancer patients on chemotherapy, organ transplant recipients, or people with prolonged IV lines or broad-spectrum antibiotic use. In healthy individuals, Candida infections are usually limited to mucosal surfaces rather than spreading to the liver. While elderly patients with liver disease are at higher risk for infections in general, the pattern that characterizes hepatic candidiasis is strongest in immunocompromised hosts.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy